Issuu is a digital publishing platform that makes it simple to publish magazines, catalogs, newspapers, books, and more online. Easily share your publications and get. Cepheid Announces FDA Clearance of Next Generation Test for MRSA Colonization. MRSA has been an infection prevention challenge for over a decade, during which, new strains have emerged, often escaping detection by conventional assays and threatening the substantial gains made in HAI prevention in recent years. To meet this challenge, Xpert MRSA Nx. G was developed utilizing an extensive library of MRSA strains collected from around the world and demonstrates unprecedented strain coverage. Integral to the new test design are updated PCR primers and probes that detect both mec. A and mec. C strains, which reduces the frequency of false positive results due to empty cassette strains. Disney College Work Study Program on this page. The test has been validated for use with both ESwab Copan and rayon swabs. MRSA surveillance remains a critical infection prevention activity for healthcare facilities and one that is challenged by the continued evolution of target sequences within MRSA, said Dr. Fred C. Tenover, Cepheids Vice President for Scientific Affairs. Fortunately, our global MRSA surveillance initiative has helped us keep ahead of the curve by alerting us to the emergence of novel strain types, enabling us to design a more comprehensive assay that takes into account major shifts, like the emergence of mec. C, as well as more subtle changes in the SCCmec targets. Active surveillance testing using rapid molecular diagnostics, along with standard infection prevention practices, have been shown to reduce the spread of MRSA in healthcare settings. Studies have shown that MRSA screening programs using on demand molecular tests contribute to Decreased MRSA infection rates in the ICU by 6. Reduced isolation days by 4. Decreased overall hospital costs. Cepheid is committed to the fight against the spread of multidrug resistant organisms. For information on our Diagnostics First education campaign, visit www. Dalet Software. Diagnostics. First. Xpert MRSA Nx. G will begin shipping in December. For more information on Cepheids Gene. Please use this address next time http MIQE Minimum Information for Publication of qPCR Experiments Checklist XLS. Cepheid Announces FDA Clearance Of Xpert Xpress Flu And Xpert Xpress FluRSV. Xpert Systems or the complete menu of Xpert tests, visit www. About Cepheid. Based in Sunnyvale, Calif., Cepheid is a leading molecular diagnostics company that is dedicated to improving healthcare by developing, manufacturing, and marketing accurate yet easy to use molecular systems and tests. By automating highly complex and time consuming manual procedures, the companys solutions deliver a better way for institutions of any size to perform sophisticated genetic testing for organisms and genetic based diseases. TB test Ultra backed by WHO recommendation Xpert MTBRIF Ultra can better diagnose TB in children and people living with HIV. Cepheid Genexpert Manual' title='Cepheid Genexpert Manual' />Through its strong molecular biology capabilities, the company is focusing on those applications where accurate, rapid, and actionable test results are needed most, such as managing infectious diseases and cancer. For more information, visit www. About Gene. Xpert Systems and Xpert Tests. With more than 1. Gene. Xpert System is the worlds most popular molecular diagnostics system. The Gene. Xpert Systems modular configuration means that the system is the most scalable available, offering the ability to perform from one to eighty Xpert tests at the same time. As a result, the Gene. Xpert System meets the throughput requirements of customers of all sizes from lower volume point of care settings to higher volume reference laboratories enabling accurate, fast and cost effective test results. Gene. Xpert Systems run proprietary Xpert test cartridges. The Xpert test menu spans healthcare associated infections, sexual health, critical infectious disease, and oncology, and today offers 2. US, and 2. 0 tests in the US. More information on the Gene. Xpert System and the Xpert tests is available on our website at www. References Bal et al. Genomic insights into the emergence and spread of international clones of healthcare, community and livestock associated methicillin resistant Staphylococcus aureus Blurring of the traditional definitions. J Glob Antimicrob Resist. Cepheid Xpert MRSA Nx. G Package Insert. Jain et al. Veterans Affairs initiative to prevent methicillin resistant Staphylococcus aureus infections. N Engl J Med. 2. 01. Wassenberg et al. Costs and benefits of rapid screening of methicillin resistant Staphylococcus aureus carriage in intensive care units a prospective multicenter study. Crit Care. 2. 01. R2. 2. Contact Darwa Peterson1 4. Media. Communicationscepheid. To view the original version on PR Newswire, visit http www. SOURCE Cepheid Related Linkshttp www.